Close Menu
Sunshine News Network
  • Home
  • Daily
    • Entertainment
  • Florida
  • Latest News
    • Opinion
  • Politics
  • Sports
  • Trending
  • USA
  • Business
  • Crime

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

What's Hot

Boktor Gardens Fruit Fest returns this weekend

July 10, 2025

Republican megaville means health costs for many Americans

July 10, 2025

Roy Jenkinspool will reopen to the community after serious damage from the hurricane

July 10, 2025
Facebook X (Twitter) Instagram
  • Home
  • Daily
    • Entertainment
  • Florida
  • Latest News
    • Opinion
  • Politics
  • Sports
  • Trending
  • USA
  • Business
  • Crime
Facebook X (Twitter) Instagram Pinterest
Sunshine News Network
  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
  • Crime
Sunshine News Network
Home » Merck spends $10 billion on Verona and accesses COPD drugs
Business

Merck spends $10 billion on Verona and accesses COPD drugs

adminBy adminJuly 10, 2025No Comments2 Mins Read0 Views
Share Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


By Michelle Chapman

Pharmaceutical giant Merck is buying Verona Pharma, a company focused on respiratory diseases in a deal of about $10 billion.

The agreement gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication. US regulators approved an inhaled medication more than a year ago to treat chronic obstructive pulmonary disease (COPD) in adults.

“Ohtuvayre will complement and expand our cardiopulmonary disease treatment pipeline and portfolio while delivering close and long-term growth and value to shareholders.”

Verona CEO David Zaccardelli added that Merck’s commercial reach will help Ohtuvayre reach more COPD patients.

According to the National Institutes of Health, COPD is a progressive disease that can cause shortness of breath, cough, cough and difficulty breathing. It is caused by damage to the airways or other parts of the lungs, affecting more than 14 million adults in the United States.

Ohtuvayre was launched last August as the first commercial product of London-based Verona Pharma. This drug has also been studied as a possible treatment for another chronic respiratory problem that worsens over time: bronchiectasis with non-cystic fibrosis.

Merck is planning to pay $107 for each share in Verona Pharma America Deposit. This represents eight of the company’s common stock.

The deal, announced Wednesday, is approved by the boards of both companies and is expected to close in the fourth quarter. However, shareholder approval and sanctions of Verona Pharma by the High Courts of England and Wales are still needed.

Shares of New Jersey-based Merck’s Raaway rose to 25 cents to $81.63 before the market opened Wednesday.

AP health writer Tom Murphy contributed to this report.

Original issue: July 9, 2025, 5:24pm EDT



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
admin
  • Website

Related Posts

Business

Samsung announces a new line of unpacked foldable devices

July 10, 2025
Business

First Campus-on Campus Housing of Full Sail Broken This Fall – Orlando Sentinel

July 10, 2025
Business

Sales that compete with Amazon Prime Day are off to a solid start

July 10, 2025
Business

Few Canadians are looking for a Florida home, data shows

July 10, 2025
Business

Trump sends customs letters to more countries rather than major trading partners

July 9, 2025
Business

Musk’s AI company scrubs posts after Grok makes anti-Semitic comments

July 9, 2025
Add A Comment
Leave A Reply Cancel Reply

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Editor's Picks

Boktor Gardens Fruit Fest returns this weekend

July 10, 2025

Republican megaville means health costs for many Americans

July 10, 2025

Roy Jenkinspool will reopen to the community after serious damage from the hurricane

July 10, 2025

Samsung announces a new line of unpacked foldable devices

July 10, 2025
Latest Posts

Florida is growing to affordable prices. Do politicians notice?

July 10, 2025

Donald Trump, Paramount Global and the ’60 Minutes’ travesty

July 10, 2025

Record-breaking state funding updates hopes for Florida citrus crops

July 9, 2025

Welcome to Sunshine News Network – your trusted source for the latest and most reliable news in Florida.

At Sunshine News Network, our mission is to provide up-to-date, in-depth coverage of everything that matters to Floridians. From breaking news and local events to lifestyle trends and weather updates, we are here to keep you informed, engaged, and connected with the Sunshine State.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Facebook X (Twitter) Instagram Pinterest
  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
  • Crime
© 2025 sunshinenewsnetwork. Designed by sunshinenewsnetwork.

Type above and press Enter to search. Press Esc to cancel.